Nuclear DNA counterstaining and nuclear morphology staining
Materials Required
Principle
Nuclear DNA counterstaining uses DNA-binding fluorescent dyes to visualize nuclei and chromatin so that nuclei can be located, counted, segmented, and evaluated for morphology; Hoechst 33342, DAPI, propidium iodide, and DRAQ5 are commonly reported nuclear stains, while live-cell DNA labeling is better supported for Hoechst dyes and DRAQ5 than for propidium iodide in intact viable cells. Nuclear morphology staining can detect apoptosis-associated nuclear changes, including chromatin condensation, nuclear shrinkage, nuclear fragmentation, reduced nuclear area/perimeter/axis length, and increased nuclear fluorescence intensity; these morphology readouts have been compared with apoptosis markers such as TUNEL and caspase-3 immunofluorescence.
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
• Use cultured cells fixed or live according to dye choice;
• Published examples include LNCaP, MDA-MB-231, ARPE-19, HL-60, MOLT-4, and P815 cells for nuclear morphology or cell-death-related nuclear staining assays.
• Use phosphate-buffered saline or equivalent washing buffer only as required by the selected published staining workflow;
• Fixation, permeabilization, and washing conditions should be matched to the selected dye and sample type rather than generalized across all dyes.
• Hoechst 33342 is supported for nuclear staining in cell-death microscopy protocols and for live-cell DNA labeling;
• DAPI is supported for fixed-cell nuclear counterstaining and morphology analysis;
• DRAQ5 is supported for live and fixed nuclear DNA labeling and far-red chromatin visualization;
• Propidium iodide is supported for DNA staining in permeabilized or nonviable cells and for distinguishing membrane-compromised/apoptotic populations in specific contexts.
• TUNEL staining and caspase-3 immunofluorescence can be used as comparator assays when nuclear morphology is interpreted as apoptosis-associated morphology rather than simple nuclear localization.
• Use fluorescence microscopy or confocal microscopy with filters or laser lines compatible with the chosen dye;
• Published nuclear morphology workflows quantify images of fluorescently stained nuclei, and live-cell dye comparisons used widefield epifluorescence and confocal laser scanning microscopy.
• Use ImageJ or comparable image-analysis software for segmentation and measurement of nuclear area, perimeter/circumference, major axis, minor axis, form factor, fluorescence intensity, and nearest-neighbor distribution when these readouts are required.
• Published examples include LNCaP, MDA-MB-231, ARPE-19, HL-60, MOLT-4, and P815 cells for nuclear morphology or cell-death-related nuclear staining assays.
• Use phosphate-buffered saline or equivalent washing buffer only as required by the selected published staining workflow;
• Fixation, permeabilization, and washing conditions should be matched to the selected dye and sample type rather than generalized across all dyes.
• Hoechst 33342 is supported for nuclear staining in cell-death microscopy protocols and for live-cell DNA labeling;
• DAPI is supported for fixed-cell nuclear counterstaining and morphology analysis;
• DRAQ5 is supported for live and fixed nuclear DNA labeling and far-red chromatin visualization;
• Propidium iodide is supported for DNA staining in permeabilized or nonviable cells and for distinguishing membrane-compromised/apoptotic populations in specific contexts.
• TUNEL staining and caspase-3 immunofluorescence can be used as comparator assays when nuclear morphology is interpreted as apoptosis-associated morphology rather than simple nuclear localization.
• Use fluorescence microscopy or confocal microscopy with filters or laser lines compatible with the chosen dye;
• Published nuclear morphology workflows quantify images of fluorescently stained nuclei, and live-cell dye comparisons used widefield epifluorescence and confocal laser scanning microscopy.
• Use ImageJ or comparable image-analysis software for segmentation and measurement of nuclear area, perimeter/circumference, major axis, minor axis, form factor, fluorescence intensity, and nearest-neighbor distribution when these readouts are required.
Experimental Procedure
• Select the nuclear dye according to sample state and spectral design: Hoechst 33342 and DRAQ5 are supported for live-cell nuclear DNA staining, DAPI is commonly used for fixed-cell nuclear counterstaining, DRAQ5 is useful when a far-red nuclear signal is needed, and propidium iodide is most appropriate when membrane permeability or nonviability is part of the assay design.
• Prepare experimental and control cell populations before staining;
• Published morphology studies compared untreated or vehicle-treated controls with apoptosis-induced cells, including cycloheximide-treated LNCaP and MDA-MB-231 cells and staurosporine-treated ARPE-19 cells.
• For Hoechst 33342 nuclear morphology staining, stain cells with Hoechst 33342 according to the published cell-death nuclear staining protocol, image nuclei by fluorescence microscopy, and classify apoptotic nuclear morphology by condensation and fragmentation rather than by dye positivity alone.
• For fixed-cell DAPI counterstaining and morphology analysis, counterstain nuclei with DAPI after sample preparation, acquire fluorescence images, and quantify nuclear morphology using parameters such as nuclear area, circumference/perimeter, form factor, and spatial distribution;
• In ARPE-19 apoptosis experiments, DAPI-stained nuclei were analyzed in ImageJ and compared with caspase-3 immunofluorescence.
• For quantitative nuclear morphology analysis in apoptosis models, acquire images of fluorescent dye-stained nuclei and measure nuclear area, perimeter, major axis, minor axis, and fluorescence brightness;
• In cycloheximide-treated LNCaP and MDA-MB-231 cells, reduced nuclear size parameters and increased nuclear staining intensity were associated with TUNEL-confirmed apoptosis.
• For live-cell chromatin visualization, use Hoechst dye or DRAQ5 rather than propidium iodide when intact viable cells must be imaged;
• Martin, Leonhardt, and Cardoso reported that only Hoechst and DRAQ5 among TOPRO-3, TOTO-3, propidium iodide, Hoechst 33258, and DRAQ5 were suitable for live-cell DNA staining under their imaging comparisons.
• For DRAQ5 staining, apply the published DRAQ5 live- or fixed-cell DNA labeling workflow when far-red nuclear DNA detection is required;
• DRAQ5 was described as membrane-permeant, DNA-selective, and compatible with fluorescence microscopy or cytometry applications.
• Analyze nuclear morphology at the single-nucleus level by segmenting fluorescent nuclei and extracting nuclear area, perimeter/circumference, major axis, minor axis, form factor, fluorescence intensity, and spatial distribution metrics;
• Apoptosis-associated morphology should be interpreted with comparator evidence such as TUNEL or caspase-3 where apoptosis is the biological conclusion.
• Use untreated or vehicle-treated cells as negative controls and apoptosis-induced cells as positive controls when the endpoint is apoptotic nuclear morphology;
• Published examples used cycloheximide-treated cells with TUNEL comparison and staurosporine-treated ARPE-19 cells with caspase-3 comparison.
• Prepare experimental and control cell populations before staining;
• Published morphology studies compared untreated or vehicle-treated controls with apoptosis-induced cells, including cycloheximide-treated LNCaP and MDA-MB-231 cells and staurosporine-treated ARPE-19 cells.
• For Hoechst 33342 nuclear morphology staining, stain cells with Hoechst 33342 according to the published cell-death nuclear staining protocol, image nuclei by fluorescence microscopy, and classify apoptotic nuclear morphology by condensation and fragmentation rather than by dye positivity alone.
• For fixed-cell DAPI counterstaining and morphology analysis, counterstain nuclei with DAPI after sample preparation, acquire fluorescence images, and quantify nuclear morphology using parameters such as nuclear area, circumference/perimeter, form factor, and spatial distribution;
• In ARPE-19 apoptosis experiments, DAPI-stained nuclei were analyzed in ImageJ and compared with caspase-3 immunofluorescence.
• For quantitative nuclear morphology analysis in apoptosis models, acquire images of fluorescent dye-stained nuclei and measure nuclear area, perimeter, major axis, minor axis, and fluorescence brightness;
• In cycloheximide-treated LNCaP and MDA-MB-231 cells, reduced nuclear size parameters and increased nuclear staining intensity were associated with TUNEL-confirmed apoptosis.
• For live-cell chromatin visualization, use Hoechst dye or DRAQ5 rather than propidium iodide when intact viable cells must be imaged;
• Martin, Leonhardt, and Cardoso reported that only Hoechst and DRAQ5 among TOPRO-3, TOTO-3, propidium iodide, Hoechst 33258, and DRAQ5 were suitable for live-cell DNA staining under their imaging comparisons.
• For DRAQ5 staining, apply the published DRAQ5 live- or fixed-cell DNA labeling workflow when far-red nuclear DNA detection is required;
• DRAQ5 was described as membrane-permeant, DNA-selective, and compatible with fluorescence microscopy or cytometry applications.
• Analyze nuclear morphology at the single-nucleus level by segmenting fluorescent nuclei and extracting nuclear area, perimeter/circumference, major axis, minor axis, form factor, fluorescence intensity, and spatial distribution metrics;
• Apoptosis-associated morphology should be interpreted with comparator evidence such as TUNEL or caspase-3 where apoptosis is the biological conclusion.
• Use untreated or vehicle-treated cells as negative controls and apoptosis-induced cells as positive controls when the endpoint is apoptotic nuclear morphology;
• Published examples used cycloheximide-treated cells with TUNEL comparison and staurosporine-treated ARPE-19 cells with caspase-3 comparison.
Troubleshooting
Problem: Nuclear staining is present, but apoptosis is overcalled.
• Possible Cause: Nuclear dye positivity alone does not distinguish ordinary nuclei from apoptotic nuclei.• Literature-supported Solution: Score morphology features such as chromatin condensation, nuclear fragmentation, reduced nuclear area/perimeter/axis length, and increased nuclear staining intensity, and use TUNEL or caspase-3 as comparator evidence when claiming apoptosis.
Problem: Live viable cells are poorly labeled with propidium iodide.
• Possible Cause: Propidium iodide uptake depends on membrane permeability and is not a general live-cell chromatin label.• Literature-supported Solution: Use Hoechst or DRAQ5 for live-cell DNA visualization when intact viable-cell chromatin labeling is required.
Problem: Nuclear morphology measurements are subjective.
• Possible Cause: Manual visual scoring can vary between observers.• Literature-supported Solution: Use image-analysis measurements such as area, perimeter/circumference, axis length, form factor, fluorescence intensity, and nearest-neighbor distribution rather than qualitative inspection alone.
Références:
- [1]. Crowley LC, et al. Analyzing Cell Death by Nuclear Staining with Hoechst 33342. Cold Spring Harb Protoc. 2016;2016(9):778-781. [Content Brief]
- [2]. Mandelkow R, et al. Detection and Quantification of Nuclear Morphology Changes in Apoptotic Cells by Fluorescence Microscopy and Subsequent Analysis of Visualized Fluorescent Signals. Anticancer Res. 2017;37(5):2239-2244. [Content Brief]
- [3]. Eidet JR, et al. Objective assessment of changes in nuclear morphology and cell distribution following induction of apoptosis. Diagn Pathol. 2014;9:92. [Content Brief]
- [4]. Martin RM, et al. DNA labeling in living cells. Cytometry A. 2005;67(1):45-52. [Content Brief]
- [5]. Smith PJ, et al. DRAQ5 labeling of nuclear DNA in live and fixed cells. Curr Protoc Cytom. 2004 May;Chapter 7:Unit 7.25. [Content Brief]
- [6]. Atale N, et al. Cell-death assessment by fluorescent and nonfluorescent cytosolic and nuclear staining techniques. J Microsc. 2014;255(1):7-19. [Content Brief]
- [7]. Costigan A, et al. Discriminating Between Apoptosis, Necrosis, Necroptosis, and Ferroptosis by Microscopy and Flow Cytometry. Curr Protoc. 2023;3(12):e951. [Content Brief]
- [8]. Zamai L, et al. Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentation. Cytometry. 1996;23(4):303-311.
LinkedIn
Researchgate
Instagram
X
Facebook
WhatsApp
Reddit
Mail